John Peter McLaughlin, Director at PDL BIOPHARMA, INC. (PDLI), sold 605,868 shares at $2.61 ($1.6M) on 2020-12-22, disclosed to the SEC on 2020-12-22.
Seasonal sale ($1.6M) by Director — this insider has traded PDLI in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.62 | 50,000 | $131K | 8.3% |
| 2 | $2.61 | 277,934 | $725K | 45.9% |
| 3 | $2.61 | 277,934 | $725K | 45.9% |
| Total | $2.61 avg | 605,868 | $1.6M | 100% |